Hambrecht & Quist Capital Management »

Crispr Therapeutics shares owned by Hambrecht & Quist Capital Management

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Hambrecht & Quist Capital Management from 13F filings

Historical chart of Hambrecht & Quist Capital Management investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by Hambrecht & Quist Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by Hambrecht & Quist Capital Management

Quarter filed Position value Share count Share price at filing
2023-06-30 $1.3M 23k 56.14
2023-03-31 $2.5M 55k 45.23
2022-12-31 $2.2M 55k 40.65
2022-09-30 $3.6M 55k 65.34
2022-06-30 $3.3M 55k 60.77
2022-03-31 $3.5M 55k 62.76
2021-12-31 $4.2M 55k 75.78
2021-09-30 $18M 162k 111.93
2021-06-30 $26M 162k 161.89
2021-03-31 $18M 151k 121.85
2020-12-31 $12M 76k 153.11
2020-09-30 $6.4M 76k 83.64
2020-06-30 $5.6M 76k 73.50
2020-03-31 $3.2M 76k 42.42
2019-12-31 $4.6M 76k 60.90
2019-09-30 $4.2M 101k 40.99
2019-06-30 $8.4M 178k 47.10
2019-03-31 $6.4M 178k 35.72
2018-12-31 $5.1M 178k 28.57
2018-09-30 $7.9M 178k 44.35
2018-06-30 $11M 178k 58.76
2018-03-31 $6.5M 141k 45.71